Skip to Main Content
Eurofins scientific: the bioanalytical company
  • Home
  • About Us
    • Leadership
    • Meeting schedule
    • ICAAC 2008
    • Contact
  • Services
    • Central Laboratory Services
    • Anti-Infective Services
    • Bioanalytical Services
    • Genomic Services
    • Biomarkers
    • Pharmacokinetics
  • Standardization
  • Quality Assurance
  • Resources
    • Scientific Presentations
  • News
  • Eurofins.com
  • Print this page
  • Contact us via email
  • Scientific Presentations

Eurofins Worldwide

Eurofins in your country

Careers at Eurofins

plan

Eurofins in your country Eurofins in your country

Eurofins Spotlight

  • Superbugs require new drugs - antibiotic resistance
  • Bottlenecks in Integrated Biomarkers Development
  • Case study: biomarker for oxidative stress
  • New Developments at Eurofins Medinet

  • Home >
  • Resources

Resources

Downloads

  • Company Profile
  • Quality Assurance
  • Standardization
  • Corporate Profile
  • Eurofins Scientific Annual Report 2006

Global Laboratory Services

  • Global Central Laboratory Services
  • Routine Safety Testing 
  • Microbiology Testing & Consultative Services
  • Microbiology Clinical Trials Services
  • The Surveillance Network (TSN)
  • Bioanalysis
  • Mass Spectrometry Based Services
  • Biomarkers
  • Genomics
  • Pharmacokinetics
  • Biomarkers at Eurofins Medinet
  • Singapore Laboratory
  • Available Methods
  • Advanced Validation of NT-proBNP in Human Plasma
  • Shanghai Laboratory
  • Denver Laboratory
  • Safety Testing
  • Immunogenicity

White Papers & Scientific Presentations

  • Biomarker for oxidative stress
  • Quantification of 11 nucleotides using LC/LC-ESI-MS
  • Development of Drug Eluting Stents
  • Scientific Presentations

Scientific Handouts

  • A new approach for the analysis of 15 Anti Epileptic Drugs (AED's) in human plasma
  • Biomarkers: from diagnostic tool to advanced validated efficacy determinations
  • Simultaneous on-line LC-MS/MS analysis of Everolimus, Tacrolimus, Sirolimus and Cyclosporin A in whole blood
  • Advanced pre-study validation of NT-proBNP determination in human plasma
  • Method validation approach for the determination of antibody response to biopharmaceuticals

 Accreditation and Certification

Breda

  • ISO 15189
  • ISO 17025
  • GLP
  • NGSP Level I
  • CDC

Washington DC

  • CLIA
  • CAP
  • NGSP Level I

Paris

  • CDC
  • COFRAC
  • CAP
  • NGSP Level I

Singapore

  • NGSP Level I
  • MOH
  • CAP

Shanghai

  •  NGSP Level 1
Home | Contact the webmaster | About Us | © 2005 - 2009

Top